China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more
Median Technologies partners with PASREL-Imagerie to deliver imaging biomarkers for oncology drugs Read more
Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL Read more